GLPG

Actualités Galapagos

Les meilleurs offres pour accéder les cours en temps réel en illimité
Intégral
Abonnement Mensuel
Seulement
19,79 €
Mini
Abonnement Mensuel
Seulement
10,55 €
Trader
Abonnement Mensuel
Seulement
34,09 €
Prix hors taxes
Nom Action Symbole Action Marché Type
Galapagos GLPG Euronext Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
1,06 2,0% 54,10 17:40:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
52,00 52,00 54,10 54,10 53,04
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
21/6/202222:03GLOBEGalapagos to acquire CellPoint and AboundBio to accelerate..
20/6/202222:01GLOBEGalapagos increases share capital through subscription right..
01/6/202222:01GLOBEGalapagos receives transparency notification from FMR LLC
25/5/202222:01GLOBEGalapagos to showcase commitment to rheumatoid arthritis..
06/5/202222:01GLOBEGalapagos creates new subscription right plans
05/5/202222:01GLOBEGalapagos demonstrates regulatory and commercial progress in..
26/4/202222:01GLOBEGalapagos announces appointment of Dr. Paul Stoffels as..
28/3/202208:01GLOBEJyseleca® approved in Japan for ulcerative colitis
24/3/202221:17GLOBECorrection: Galapagos publishes 2021 annual report and..
24/3/202221:01GLOBEGalapagos publishes 2021 annual report and announces..
18/3/202222:01GLOBEGalapagos increases share capital through subscription right..
24/2/202222:01GLOBEGalapagos 2021 results set stage for future growth
03/2/202222:01GLOBEGalapagos receives transparency notification from EcoR1..
02/2/202222:01GLOBEGalapagos provides further insights into the treatment of..
26/1/202222:40GLOBEGalapagos creates new subscription right plan
26/1/202222:01GLOBEGalapagos appoints Paul Stoffels as Chief Executive Officer
18/1/202222:01GLOBEJYSELECA®▼ (FILGOTINIB) LICENSED FOR THE TREATMENT OF ADULT..
13/1/202222:01GLOBEGalapagos creates new subscription right plan
06/1/202215:30GLOBEGalapagos to present at 40th Annual J.P. Morgan Healthcare..
03/12/202122:01GLOBEGalapagos increases share capital through subscription right..
22/11/202122:01GLOBEGalapagos completes patient recruitment for MANGROVE Phase 2..
15/11/202116:45GLOBEJyseleca®▼(filgotinib) approved in the European Union for..
04/11/202122:01GLOBEGalapagos reports commercial and operational progress at Q3..
04/10/202122:01GLOBEGalapagos presents new data from the SELECTION Phase 3..
04/10/202107:01GLOBEGalapagos announces completion of patient enrollment for..
20/9/202122:01GLOBEGalapagos increases share capital through subscription right..
17/9/202113:15GLOBEGALAPAGOS ANNOUNCES POSITIVE CHMP OPINION FOR JYSELECA®..
30/8/202123:28DJNGalapagos NV CEO to Retire
30/8/202122:01GLOBEGalapagos announces planned retirement of CEO
05/8/202122:01GLOBEGalapagos reports H1 financial results with refocused..
15/7/202117:59DJNGalapagos ADRs Down After Study Data
14/7/202122:01GLOBEGalapagos demonstrates early clinical activity with SIK2/3..
10/7/202111:10GLOBEGalapagos announces new data supporting rapid symptom..
Dernières Valeurs Consultées
EU
GLPG
Galapagos
Inscrivez-vous aujourd'hui pour consulter ce titre en streaming sur le Moniteur ADVFN. Vous pourrez ajouter et visualiser jusqu'à 110 des vos actions préférée et c'est complètement gratuit..

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

P: V: D:20220703 09:32:53